Concepedia

Joachim Wernicke

JW

Statistics

Publications

22

Citations

4.2K

H-Index

18

Active since

1971

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Eli Lilly (Canada)

Massachusetts General Hospital

Joachim Wernicke is an author at Eli Lilly (United States) specializing in pharmacotherapy, pharmacology, and medicine.

Publications per year

1971–2013

22

Publications

22

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

David Michelson, Lenard A. Adler, Thomas Spencer et al. · Biological Psychiatry · 2003 · 789 citations

, , +12

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 669 citations

, , +17

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

David Michelson, Albert J. Allen, Joan Busner et al. · American Journal of Psychiatry · 2002 · 600 citations

, , +17

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Joel Raskin, Yili Pritchett, Fujun Wang et al. · Pain Medicine · 2005 · 530 citations · Full text

, , +17

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Lesley M. Arnold, A. Rosen, Yili Pritchett et al. · Pain · 2005 · 473 citations

, , +17

1–5 of 22